InMed has 180 days to lift its stock above $1 and stay on Nasdaq

robot
Abstract generation in progress

InMed Pharmaceuticals (NASDAQ: INM) has received a Nasdaq notification that its stock price fell below the minimum $1.00 requirement for 30 consecutive trading days, from February 11, 2026, to March 26, 2026. The company has 180 calendar days to regain compliance by achieving a closing bid price of at least $1.00 for 10 consecutive business days, during which its shares will continue to trade under the symbol INM. Should it fail, InMed may be eligible for an additional 180-day grace period if it meets other listing standards, possibly utilizing a reverse stock split.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin